Short Interest in Enzolytics, Inc. (OTCMKTS:ENZC) Rises By 115.6%

Enzolytics, Inc. (OTCMKTS:ENZC) was the recipient of a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 1,260,500 shares, a growth of 115.6% from the September 30th total of 584,700 shares. Based on an average daily volume of 17,960,300 shares, the days-to-cover ratio is currently 0.1 days.

Enzolytics Price Performance

Shares of ENZC remained flat at $0.00 during midday trading on Friday. 9,293,308 shares of the stock were exchanged, compared to its average volume of 10,409,088. Enzolytics has a 52 week low of $0.00 and a 52 week high of $0.03.

Enzolytics Company Profile

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.